Drug resistant Mycobacterium tuberculosis in Mexico
Tuberculosis (TB) remains a serious public health problem, worsened by an increased frequency of multidrug-resistant (MDR) Mycobacterium tuberculosis strains. The World Health Organization (WHO) and the International Union Against Tuberculosis and Lung Disease (IUATLD) launched the Global Project on...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
The Journal of Infection in Developing Countries
2009-04-01
|
| Series: | Journal of Infection in Developing Countries |
| Subjects: | |
| Online Access: | https://jidc.org/index.php/journal/article/view/31 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850149103860711424 |
|---|---|
| author | Jorge Zazueta-Beltran Claudia Leon-Sicairos Adrian Canizalez-Roman |
| author_facet | Jorge Zazueta-Beltran Claudia Leon-Sicairos Adrian Canizalez-Roman |
| author_sort | Jorge Zazueta-Beltran |
| collection | DOAJ |
| description | Tuberculosis (TB) remains a serious public health problem, worsened by an increased frequency of multidrug-resistant (MDR) Mycobacterium tuberculosis strains. The World Health Organization (WHO) and the International Union Against Tuberculosis and Lung Disease (IUATLD) launched the Global Project on Anti-Tuberculosis Drug Resistance Surveillance to measure the prevalence of drug resistance. Data from the global reports on resistance to anti-tuberculosis (anti-TB) drugs have shown that drug resistance still presents worldwide and that MDR-TB is present in almost all the world. Though the Global Project (WHO) has been operating since 1994, very few countries and states have reported new information. Data from repeated surveys employing comparable methodologies over several years are essential to determine with any certainty in which direction the prevalence of drug resistance is moving. Drug-resistant tuberculosis and MDR-TB have been identified in Mexico, even with the existence of a National Tuberculosis Program based on Directly Observed Treatment, Short-course (DOTS). This review discusses available surveillance data on drug susceptibility data for TB in different states of Mexico. |
| format | Article |
| id | doaj-art-36042ff2d48d42d9bcf53d9d288d92ce |
| institution | OA Journals |
| issn | 1972-2680 |
| language | English |
| publishDate | 2009-04-01 |
| publisher | The Journal of Infection in Developing Countries |
| record_format | Article |
| series | Journal of Infection in Developing Countries |
| spelling | doaj-art-36042ff2d48d42d9bcf53d9d288d92ce2025-08-20T02:27:01ZengThe Journal of Infection in Developing CountriesJournal of Infection in Developing Countries1972-26802009-04-0130310.3855/jidc.31Drug resistant Mycobacterium tuberculosis in MexicoJorge Zazueta-Beltran0Claudia Leon-Sicairos1Adrian Canizalez-Roman2The Sinaloa State Public Health Laboratory, Secretary of Health, 80020 Culiacan Sinaloa, MexicoAutonomous University of Sinaloa, School of NutritionThe Sinaloa State Public Health Laboratory, Secretary of Health, 80020 Culiacan Sinaloa, MexicoTuberculosis (TB) remains a serious public health problem, worsened by an increased frequency of multidrug-resistant (MDR) Mycobacterium tuberculosis strains. The World Health Organization (WHO) and the International Union Against Tuberculosis and Lung Disease (IUATLD) launched the Global Project on Anti-Tuberculosis Drug Resistance Surveillance to measure the prevalence of drug resistance. Data from the global reports on resistance to anti-tuberculosis (anti-TB) drugs have shown that drug resistance still presents worldwide and that MDR-TB is present in almost all the world. Though the Global Project (WHO) has been operating since 1994, very few countries and states have reported new information. Data from repeated surveys employing comparable methodologies over several years are essential to determine with any certainty in which direction the prevalence of drug resistance is moving. Drug-resistant tuberculosis and MDR-TB have been identified in Mexico, even with the existence of a National Tuberculosis Program based on Directly Observed Treatment, Short-course (DOTS). This review discusses available surveillance data on drug susceptibility data for TB in different states of Mexico.https://jidc.org/index.php/journal/article/view/31Mexico |
| spellingShingle | Jorge Zazueta-Beltran Claudia Leon-Sicairos Adrian Canizalez-Roman Drug resistant Mycobacterium tuberculosis in Mexico Journal of Infection in Developing Countries Mexico |
| title | Drug resistant Mycobacterium tuberculosis in Mexico |
| title_full | Drug resistant Mycobacterium tuberculosis in Mexico |
| title_fullStr | Drug resistant Mycobacterium tuberculosis in Mexico |
| title_full_unstemmed | Drug resistant Mycobacterium tuberculosis in Mexico |
| title_short | Drug resistant Mycobacterium tuberculosis in Mexico |
| title_sort | drug resistant mycobacterium tuberculosis in mexico |
| topic | Mexico |
| url | https://jidc.org/index.php/journal/article/view/31 |
| work_keys_str_mv | AT jorgezazuetabeltran drugresistantmycobacteriumtuberculosisinmexico AT claudialeonsicairos drugresistantmycobacteriumtuberculosisinmexico AT adriancanizalezroman drugresistantmycobacteriumtuberculosisinmexico |